Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 3, 1999, Pages 1179-1187

  Banes, A ^a   Florian, J A ^a   Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ANGIOTENSIN; CALPHOSTIN C; CHELERYTHRINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NIFEDIPINE; PROTEIN TYROSINE KINASE INHIBITOR; SEROTONIN; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG; UO 126; WORTMANNIN;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; AORTA, THORACIC; BLOTTING, WESTERN; ENZYME INHIBITORS; ISOENZYMES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SIGNAL TRANSDUCTION;

EID: 0032748866     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Adam LP, Haeberle JR and Hathaway DR (1989) Phosphorylation of caldeSmon in arterial smooth muscle. J Biol Chem 264:7698-7703.
2. Arcaro A and Wyman MP (1993) Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: The role of phosphatidylinositol 3,4,5 trisphosphate in neutrophil responses. Biochem J 296:297-301.
3. Bruns RF, Miller FD, Merriman RL, Howbert JJ, Heath WF, Kobayashi E, Takahashi I, Tamaoki T and Nakano H (1991) Inhibition of protein kinase C by calphostin C is light-dependent. Biochem Biophys Res Commun 176:288-293.
4. Buchdunger E, Trinks U, Mett H, Regenass U, Muller M, Meyer T, McGlynn E, Pinna LA, Traxler P and Lydon NB (1994) 4,5-Dianilinophthalimide: A protein tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity. Proc Natl Acad Sci USA 91:2334-2338.
5. Chopra LC, Hucks D, Twort CHC and Ward JPT (1997) Effects of protein tyrosine kinase inhibitors on contractility of isolated bronchioles of the rat. Am J Respir Cell Mol Biol 16:372-378.
6. Coffer PJ, Jin J and Woodgett JR (1998) Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 335:1-13.
7. Cowen DS, Sowers RS and Manning DR (1996) Activation of a mitogen-activated protein kinase (ERK2) by the 5-hydroxytryptaminelA receptor is sensitive not only to inhibitors of phosphatidylinositol 3-kinase, but to an inhibitor of phosphatidylcholine hydrolysis. J Biol Chem 271:22297-22300.
8. Daub H, Weiss FU, Wallasch C and Ullrich A (1996) Role of transactivation of the EGF receptor in signalling by G protein coupled receptors. Nature (Lond) 379: 557-560.
9. 1A receptor-mediated Erk activation requires calcium/calmodulin dependent receptor endocytosis. J Biol Chem 274:4749-4753.
10. Dudley DT, Pang L, Decker SJ, Bridges AJ and Saltiel AR (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689.
11. Dulin NO, Sorokin A and Douglas JG (1998) Arachidonate-induced tyrosine phosphorylation of epidermal growth factor receptor and Shc-Grb2-Sos association. Hypertension 32:1089-1093.
12. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F and Inagami T (1998) Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273:8890-8896.
13. Favata MG, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser SW, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA and Trzaskos JM (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632.
14. 2A receptor signal transduction. J Pharmacol Exp Ther 284:346-355.
15. Fruman DA, Meyers RE and Cantley LC (1998) Phosphoinositide kinases. Annu Rev Biochem 67:481-507.
16. Gutkind JS (1998) The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 273:1839-1842.
17. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA and Connelly PA (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J Biol Chem 271:695-701.
18. Herbert JM, Augereau JM, Gleye J and Maffrand JP (1990) Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172:993-999.
19. Ishida M, Ishida T, Thomas SM and Berk BC (1998) Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res 92:7-12.
20. Ishida M, Marrero MB, Schieffer B, Ishida T, Bernstein KE and Berk BC (1995) Angiotensin II activates pp60 c-Src in vascular smooth muscle cells. Circ Res 77:1053-1059.
21. Iwasaki H, Eguchi S, Marumo F and Hirata Y (1998) Endothelin-1 stimulates DNA synthesis of vascular smooth muscle cells through transactivation of epidermal growth factor receptor. J Cardiovasc Pharmacol 31:S182-S184.
22. Jin N, Siddiqui RA, English D and Rhoades RA (1996) Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle. Am J Physiol 271:H1348-H1355.
23. Keely SJ, Uribe JM and Barrett KE (1998) Carbachol stimulates transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T84 cells. J Biol Chem 273:27111-27117.
24. Kelleher MD, Abe MK, Chao TSO, Jain M, Green JM, Solway J, Rosner MR and Hershenson MB (1995) Role of MAP kinase activation in bovine tracheal smooth muscle mitogenesis. Am J Physiol 268:L894-L901.
25. ras. Proc Natl Acad Sci USA 91:12706-12710.
26. Lopez-Ilasaca M, Crespo P, Pellici PG, Gutkind JS and Wetzker R (1997) Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI3-kinaseγ. Science (Wash DC) 275:394-397.
27. Marais R, Light Y, Mason C, Paterson H, Olson MF and Marshall CJ (1998) Requirement of Ras-GTP-Raf complexes for activation of raf-1 by protein kinase C. Science (Wash DC) 280:109-112.
28. Nakanishi S, Kakita S, Takahashi I, Kawahara K, Tsukuda E, Sano T, Yamada K, Yoshida M, Kase H and Matsuda Y (1992) Wortmannin, a microbial product inhibitor of myosin light chain kinase. J Biol Chem 267:2157-2163.
29. 2C): Where structure meets function. Pharmacol Ther 79: 231-257.
30. Schindler T, Sicheri F, Pico A, Gazit A, Levitzki A and Kuriyan J (1999) Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol Cell 3:639-648.
31. Schlessinger J (1993) How receptor tyrosine kinases activate ras. Trends Biochem Sci 18:273-275.
32. Schonwasser DC, Marais RM, Marshall CJ and Parker PJ (1998) Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 18:790-798.
33. Semenchuk LA and DiSalvo J (1995) Receptor-activated increases in intracellular calcium and protein tyrosine phosphorylation in vascular smooth muscle cells. FEBS Lett 370:127-130.
34. Soltoff SP (1998) Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G protein coupled P2Y2 receptor. J Biol Chem 273:23110-23117.
35. Thomason PA, James SR, Casey PJ and Downes CP (1994) A G protein βγ-subunit-responsive phosphoinositide 3-kinase activity in human platelet cytosol. J Biol Chem 269:16525-16528.
36. Ui M, Okada T, Hazeki K and Hazeki O (1995) Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem Sci 20:303-307.
37. Vlahos CJ, Matter WF, Hui KY and Brown RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241-5248.
38. Walker TR, Moore SM, Lawson MF, Panettieri RA and Chilvers ER (1998) Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: Role in mediating airway smooth muscle proliferation. Mol Pharmacol 54:1007-1015.
39. Watts SW (1996) Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: Use of the mitogen-activated protein kinase kinase inhibitor PD098059. J Pharmacol Exp Ther 279:1541-1550.
40. Watts SW, Yeum CH, Campbell G and Webb RC (1996) Serotonin stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase. J Vasc Res 33:288-298.